ImmunoGen Correlations

IMGNDelisted Stock  USD 18.20  0.81  4.26%   
The current 90-days correlation between ImmunoGen and Madrigal Pharmaceuticals is 0.06 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ImmunoGen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ImmunoGen moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

ImmunoGen Correlation With Market

Significant diversification

The correlation between ImmunoGen and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ImmunoGen and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Moving together with ImmunoGen Stock

  0.92T ATT Inc Aggressive PushPairCorr
  0.78CSCO Cisco SystemsPairCorr
  0.73AA Alcoa Corp Fiscal Year End 15th of January 2025 PairCorr
  0.85WMT Walmart Aggressive PushPairCorr
  0.65BAC Bank of America Aggressive PushPairCorr
  0.86TRV The Travelers Companies Fiscal Year End 17th of January 2025 PairCorr
  0.7CAT Caterpillar Fiscal Year End 3rd of February 2025 PairCorr

Moving against ImmunoGen Stock

  0.78VNTN VentureNet CapitalPairCorr
  0.72MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.41JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.35PFE Pfizer Inc Fiscal Year End 4th of February 2025 PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
MCRBTERN
TGTXMDGL
HEPAICPT
MREOICPT
PDSBVKTX
PDSBMREO
  
High negative correlations   
PDSBTGTX
MREOTGTX
PDSBAXSM
MCRBTGTX
PDSBMDGL
TERNTGTX

Risk-Adjusted Indicators

There is a big difference between ImmunoGen Stock performing well and ImmunoGen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ImmunoGen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MDGL  2.57  0.37  0.12  1.55  2.16 
 4.92 
 30.27 
ICPT  2.96 (0.84) 0.00 (1.25) 0.00 
 5.23 
 38.17 
TGTX  2.79  0.25  0.09  0.22  3.30 
 7.34 
 24.51 
TERN  3.39 (0.43) 0.00 (0.29) 0.00 
 5.68 
 34.09 
HEPA  3.90 (0.11)(0.02) 0.01  4.43 
 8.06 
 33.54 
VKTX  3.51 (0.39) 0.00 (0.18) 0.00 
 6.24 
 34.61 
AXSM  1.68  0.07  0.02  0.21  1.87 
 4.10 
 13.67 
MCRB  4.49  0.06  0.00  0.39  5.43 
 10.00 
 26.87 
MREO  2.62 (0.41) 0.00 (0.18) 0.00 
 5.14 
 19.32 
PDSB  3.22 (0.85) 0.00 (0.42) 0.00 
 5.77 
 31.83 

View ImmunoGen Related Equities

 Risk & Return  Correlation

ImmunoGen Corporate Management

Still Interested in ImmunoGen?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.